Who owns Array BioPharma?

Key details on Array BioPharma (Ticker: ARRY)

Who owns Array BioPharma?

Is ARRY a good stock to own? Find out who bought Array BioPharma, who sold Array BioPharma (ARRY) stock, and who holds a large position in Array BioPharma.

Fund Name Number of Shares Share Valuation As Of
Redmile 11.86M $56.09M Dec. 31, 2014
Deerfield Management Company 11.83M $55.98M Dec. 31, 2014
BVF 11.77M $55.68M Dec. 31, 2014
FMR 11.45M $40.89M Sept. 30, 2014
T. Rowe Price Associates 8.69M $41.12M Dec. 31, 2014
OrbiMed Advisors 7.25M $34.28M Dec. 31, 2014
BlackRock Fund Advisors 5.08M $24.03M Dec. 31, 2014
STATE STREET CORPORATION 4.84M $22.90M Dec. 31, 2014
Vanguard 4.39M $20.75M Dec. 31, 2014
TimesSquare Capital Management 4.09M $19.36M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 3.97M $18.79M Dec. 31, 2014
Gail Mannix 3.93M $18.57M Dec. 31, 2014
Artal Group S.A. 3.31M $15.66M Dec. 31, 2014
Apex Capital 3.10M $11.07M Sept. 30, 2014
Kopp Investment Advisors 2.81M $17.47M Sept. 30, 2013
GMT Capital 2.46M $12.07M March 31, 2013
QVT Financial 2.39M $8.54M Sept. 30, 2014

Who sold Array BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management June 30, 2011 4.40M $9.85M